2,4,6-tribromophenol has been researched along with Drug-Induced Stevens Johnson Syndrome in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 41-year-old woman was given celecoxib (Celebrex) for the treatment of carpal tunnel syndrome." | 3.71 | Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). ( Friedman, B; Law, E; Orlet, HK; Still, JM, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, B | 1 |
| Orlet, HK | 1 |
| Still, JM | 1 |
| Law, E | 1 |
| Barone, CM | 1 |
| Bianchi, MA | 1 |
| Lee, B | 1 |
| Mitra, A | 1 |
2 other studies available for 2,4,6-tribromophenol and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carpal Tunnel Syndrome; Celec | 2002 |
Treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome in children.
Topics: Adolescent; Bacitracin; Bandages; Body Surface Area; Child; Child, Preschool; Female; Fluid Therapy; | 1993 |